Recursion Pharmaceuticals-a share price logo

Recursion Pharmaceuticals-a Share Price

NASDAQ: RXRX

Mid Cap

$6.80

+0.91

(+15.45%)

as on

Recursion Pharmaceuticals-a Stock Performance

as on October 16, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $6.02
    $6.82
    downward going graph

    11.47%

    Downside

    0.29%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $3.79
    $12.36
    downward going graph

    44.26%

    Downside

    81.76%

    Upside

    downward going graph

Recursion Pharmaceuticals-a share price movements today

Previous Close
$5.89
Open
$6.04
Volume
202.7M
Day's Low - High
$6.02 - $6.82
52 Week Low - High
$3.79 - $12.36

Recursion Pharmaceuticals-a Historical Returns

1 Month Return
+ 23.48 %
3 Month Return
+ 12.84 %
1 Year Return
-11.69 %
3 Year Return
-43.85 %
5 Year Return
0 %

Recursion Pharmaceuticals-a Stock Fundamentals & Key Indicators

Check Recursion Pharmaceuticals-a market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.4B

EPS (TTM)

-1.5845

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-5.41

Industry PE ratio

8.355964912280701

PEG Ratio

0

EBITDA

-586.4M

Revenue (TTM)

64.6M

Profit Margin

0.00%

Return On Equity TTM

46351000.00%

Recursion Pharmaceuticals-a Stock Valuation

Track how Recursion Pharmaceuticals-a P/E has moved over time to understand its valuation trends.

Recursion Pharmaceuticals-a in the last 5 years

  • Overview

  • Trends

Lowest (-17.36x)

June 30, 2021

Today (-5.41x)

October 15, 2025

Industry (8.36x)

October 15, 2025

Highest (-2.76x)

June 30, 2025

LowHigh

Today’s Price to Earnings Ratio: -5.41x

Recursion Pharmaceuticals-a vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Recursion Pharmaceuticals-a with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$2.4BNA-5.410.00%
BUY$60.9B226.08%-505.15-12.96%
NA$37.1BNANA-3.89%
BUY$104.4B91.48%28.9931.86%
BUY$59.1B-2.15%14.0731.37%

Stock Returns calculator for Recursion Pharmaceuticals-a Stock including INR - Dollar returns

The Recursion Pharmaceuticals-a stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Recursion Pharmaceuticals-a investment value today

Current value as on today

₹1,06,780

Returns

₹6,780

(+6.78%)

Returns from Recursion Pharmaceuticals-a Stock

₹1,949 (+1.95%)

Dollar Returns*

₹4,831 (+4.83%)

Analyst Recommendation on Recursion Pharmaceuticals-a Stock

Based on 13 analysts

BUY

53.85%

Buy

46.15%

Hold

0.00%

Sell

Based on 13 analysts, 53.85% of analysts recommend a 'BUY' rating for Recursion Pharmaceuticals-a. Average target price of $6.47

Recursion Pharmaceuticals-a Share Price Target

Get share price movements and forecasts by analysts on Recursion Pharmaceuticals-a.

What analysts predicted

-5.1%DOWNSIDE

Target Price

$6.47

Current Price

$6.8

Analyzed by

13 Analysts

Target

$6.47

Recursion Pharmaceuticals-a target price $6.47, a slight downside of -5.1% compared to current price of $6.8. According to 13 analysts rating.

Recursion Pharmaceuticals-a Stock’s Investor Sentiment and Interest

Investment in Recursion Pharmaceuticals-a Shares on INDmoney has grown by 19.62% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:19.62% versus previous 30 day period

Search interest for Recursion Pharmaceuticals-a Stock has increased by 130% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:130% versus previous 30 day period

Recursion Pharmaceuticals-a Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
12
11
10
10
13
14
26
4
14
19
Gross Profit
0
1
0
-12
0
1
14
-8
-7
-1
Operating Income
-69
-81
-99
-109
-96
-100
-98
-183
-191
-176
EBITDA
-59
-69
-85
-93
-84
-89
-87
-165
-182
-147
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
3
5
7
7
7
8
7
12
19
23
Income Before Tax
-65
-76
-93
-94
-92
-98
-95
-178
-202
-171
Income Tax Expense
-4
-5
1
-1
0
0
0
0
0
-
Net Income
-60
-76
-93
-92
-91
-97
-95
-178
-202
-171
Net Profit Margin
-500.98%
-696.50%
-920.78%
-853.88%
-662.41%
-676.56%
-366.82%
-3965.99%
-1373.26%
-899.84%

Recursion Pharmaceuticals-a Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
1
3
10
39
44
58
Gross Profit
-44
-59
10
-8
1
13
Operating Income
-62
-84
-182
-245
-350
-479
EBITDA
-58
-81
-174
-233
-299
-426
Interest Expense
0
1
2
0
0
1
Depreciation
3
4
8
11
20
36
Income Before Tax
-61
-87
-186
-239
-332
-464
Income Tax Expense
0
0
-8
0
-4
-1
Net Income
-62
-87
-178
-239
-328
-463
Net Profit Margin
-3654.30%
-2574.92%
-1780.74%
-603.36%
-735.99%
-788.02%

Recursion Pharmaceuticals-a Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-76
-93
-92
-91
-97
-95
-178
-202
-171
Operating Cash Flow
-67
-72
-74
-102
-82
-59
-115
-131
-76
Investing Cash Flow
-2
0
-2
-6
-4
-4
275
-7
-5
Financing Cash Flow
3
53
80
13
263
16
10
40
97
Change in Cash
-65
-19
5
-95
176
-40
167
-93
24

Recursion Pharmaceuticals-a Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-87
-186
-239
-328
-463
Operating Cash Flow
-45
-158
-83
-287
-359
Investing Cash Flow
-8
-271
193
-10
260
Financing Cash Flow
246
458
154
140
304
Change in Cash
191
28
263
-157
201

Global Institutional Holdings in Recursion Pharmaceuticals-a

Funds
Holdings
Vanguard Group Inc
8.26%
ARK Investment Management LLC
7.56%
BlackRock Inc
6.5%
Baillie Gifford & Co Limited.
5.54%
SoftBank Group Corp
3.36%

Recursion Pharmaceuticals-a News & Key Events

  • img

    Today's Timeline - 08 October

    Wed, 00:21 AM

    -

    Recursion Pharmaceuticals stock surges 17.21% amid strong Q2 revenue, despite missing loss estimates and workforce reduction.

Insights on Recursion Pharmaceuticals-a

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, RXRX stock has moved up by 23.5%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -202.48M → -171.89M (in $), with an average increase of 17.8% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 4.51M → 19.10M (in $), with an average increase of 46.1% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 63.3% return, outperforming this stock by 75.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 153.0% return, outperforming this stock by 196.9%

About Recursion Pharmaceuticals-a

recursion pharmaceuticals has developed a powerful drug discovery platform involving millions of rapid, automated experiments and analysis to discover new therapeutics. our platform has resulted in the massive parallelization of drug discovery. we have deployed this platform in pursuit of drugs for the treatment of rare genetic diseases. we partner or out-license these leads to major pharmaceutical companies early in development. our horizontal business model focused on discovery accelerates our impact and reduces our costs by avoiding slow and costly in-house development, and allows us to spread risk across many new therapeutic opportunities.
OrganisationRecursion Pharmaceuticals-a
Headquarters41 South Rio Grande Street, Salt Lake City, UT, United States, 84101
IndustryServices
CEODr. Christopher C. Gibson Ph.D.
E-voting on sharesClick here to vote

Key Management of Recursion Pharmaceuticals-a

Name

Title

Dr. David J. Mauro M.D., Ph.D.

Chief Medical Officer

Dr. Najat Khan Ph.D.

Chief R&D Officer, Chief Commercial Officer and Director

Ms. Kristen Rushton M.B.A.

Chief Operating Officer

Mr. Nathan Hatfield J.D., M.B.A.

Chief Legal Officer & Corporate Secretary

Ms. Erica Fox

Chief People and Impact Officer

Mr. Matthew Kinn M.B.A.

Chief Business Officer

Dr. Christopher C. Gibson Ph.D.

Co-Founder, CEO & Director

Mr. Ben R. Taylor

CFO & President of Recursion UK

Mr. Benjamin Mabey M.S.

Chief Technology Officer

Dr. David Hallett Ph.D.

Chief Scientific Officer

FAQs

What is Recursion Pharmaceuticals-a share price today?

Recursion Pharmaceuticals-a share price today is $6.8 as on at the close of the market. Recursion Pharmaceuticals-a share today touched a day high of $6.82 and a low of $6.02.

What is the 52 week high and 52 week low for Recursion Pharmaceuticals-a share?

Recursion Pharmaceuticals-a share touched a 52 week high of $12.36 on and a 52 week low of $3.79 on . Recursion Pharmaceuticals-a stock price today i.e. is closed at $6.8,which is 44.98% down from its 52 week high and 79.42% up from its 52 week low.

What is Recursion Pharmaceuticals-a's market capitalisation today?

Recursion Pharmaceuticals-a market capitalisation is $0.00T as on .

How to invest in Recursion Pharmaceuticals-a Stock (RXRX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Recursion Pharmaceuticals-a on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Recursion Pharmaceuticals-a Shares that will get you 0.2206 shares as per Recursion Pharmaceuticals-a share price of $6.8 per share as on October 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy Recursion Pharmaceuticals-a Stock (RXRX) from India?

Indian investors can start investing in Recursion Pharmaceuticals-a (RXRX) shares with as little as ₹87.985 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹879.85 in Recursion Pharmaceuticals-a stock (as per the Rupee-Dollar exchange rate as on ). Based on Recursion Pharmaceuticals-a share’s latest price of $6.8 as on October 16, 2025 at 1:29 am IST, you will get 1.4706 shares of Recursion Pharmaceuticals-a. Learn more about fractional shares .